RTTNews | Jan 7, 2021 10:06AM EST

10:06 Thursday, January 7, 2021 (RTTNews.com) - Shares of CureVac N.V. (CVAC) jumped 15% on Thursday morning after the German biotech company announced partnership with Bayer AG to develop coronavirus vaccine.

CVAC is currently trading at $100.65, up $13.80 or 15.89%, on the Nasdaq.

Bayer has signed a collaboration and services agreement with CureVac under which Bayer will support the further development, supply and key territory operations of CureVac's COVID-19 vaccine candidate CVnCoV.

Bayer will contribute its expertise and established infrastructure in areas such as clinical operations, regulatory affairs, pharmacovigilance, medical information, supply chain performance as well as support in selected countries.

Read the original article on RTTNews ( https://www.rttnews.com/3158593/stock-alert-curevac-jumps-13-on-partnership-with-bayer-to-develop-covid-vaccine.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved